baber/WOPTO huggingface dataset:
Patent CA-2413782-A1 (CA)
Inventor: ESKELDSON DAVID D
IPC: H04L1/24
Filed: 2002-12-09
Abstract: Delay induced apparent amplitude desensitization in a data signal channel and its accompanying worm-like distortion in an Eve Diagram Analyzer is avoided by altering the measurement to avoid the need for any substantial delay in the path of the data channel threshold comparison signals. In a first technique, only enough delay will be inserted in the data channels to produce the relative adjustments needed to compensate for skew between the data channels, as determined by a calibration operation, and it is these de-skewed, but otherwise un-delayed, data threshold comparison signals that are, in rapid succession, clocked into the latches whose difference registers a hit at a given (time, voltage) pair. The clock path delay is then varied from a minimal value to a sufficiently large value capable of spanning a desired the number of eye diagram cycles. In a second technique, the needed amounts of de-skew delay found by the calibration operation are noted, and then the actual delays in the data path are set back to zero. The clock path delay is swept as in the first technique. The de-skewing operation is then performed in post-processing that produces the eye diagram after the measurement is complete. In either technique, the short width of transitions in the data threshold comparison signals that are associated with threshold values near the extremes of data signal excursion are no longer swallowed by the finite bandwidth of a long delay line, since the delay lines in the data channel paths now either introduce only just enough delay to compensate for skew (and those amounts are very short), or, do not introduce any extra delay at all.
Patent CA-2414484-A1 (CA)
Title: Muscle-strengthening drugs and anti-inflammatory drugs
Inventor: TSUJI KUNIRO
IPC: A61K36/38
Filed: 2002-12-16
Abstract: An object of the present invention is to provide a pharmaceutical agent or composition useful as a muscle-strengthening drug, an anti-inflammatory drug, an antiasthmatic, an antidiarrheal, an antidepressant, or a drug for the treatment of secondary diseases following cerebral infarction, motor paralysis, diminution of vision, hepatitis, inflammatory intestinal syndrome, functional enteropathy, functional cardiopathy, functional hepatopathy, functional nephropathy, dementia, climacteric symptoms, senile dementia and/or Alzheimer disease, and a dermatological agent or composition suitable for skin applications, which can treat or prevent muscle weakening and inflammation, in particular arthritis, by its muscle-strengthening and/or anti-inflammatory actions, said agent or composition comprising isoflavone and/or isoflavone glycoside in combination with a pungent substance, a bitter substance or a sour substance, and cholic acid, and/or scymnol and/or a scymnol ester. The present invention relates to an agent or composition usuful as a muscle-strengthening drug, an anti-inflammatory drug, an antiasthmatic, an antidiarrheal, an antidepressant, or a drug for the treatment of secondary diseases following cerebral infarction, motor paralysis, diminution of vision, hepatitis, inflammatory intestinal syndrome, functional enteropathy, functional cardiopathy, functional hepatopathy, functional nephropathy, dementia, climacteric symptoms, senile dementia and/or Alzheimer disease, and/or an agent or composition to be applied to the skin, said agent or composition comprising isoflavone and/or isoflavone glycoside in combination with a pungent substance, a bitter substance or a sour substance, and cholic acid, and/or scymnol and/or a scymnol ester.
Patent CA-2414877-A1 (CA)
Title: Systeme de radiodiffusion interactif
Inventor: MUZAFFAR SAJ
IPC: H04H20/00
Filed: 2001-07-03
Abstract: L'invention concerne un système de réception pour recevoir un programme de radiodiffusion en mode interactif. Ce système comprend un récepteur de télévision (1) et un dispositif de réseau sans fil, comme un téléphone mobile WAP (2) commandé par le destinataire du programme (c'est-à-dire l'utilisateur). L'utilisateur utilise le dispositif de réseau sans fil pour générer et transmettre des données numériques à l'organisme de radiodiffusion de programmes en mode interactif. Par exemple, le programme de radiodiffusion peut être un jeu radiophonique et l'utilisateur peut envoyer des réponses aux questions posées à partir du dispositif de réseau sans fil. Un site Internet fonctionnant avec le système WAP est hébergé sur un serveur (3) et est synchronisé avec le programme de radiodiffusion.
Patent CA-2415272-A1 (CA)
Title: Improvements in and relating to the use of honey in dressings
Inventor: CASKEY PHILLIP ROY
IPC: A61K45/00
Filed: 2001-06-29
Abstract: A method of manufacturing a dressing (1) which incorporates a honey composition (7) and a base material (2) is disclosed. The method includes the steps of preparing the honey composition (7) and of the base material (2), characterised by a change in the physical characteristics of the base material (2). The dressing (1) may inlcude additional agents (3) either in the honey composition (7) or the base material (7) or both. The dressing can include further layers for adhesion; be covered with a waxed material and packaged. The dressing can be applied to a wide range of wounds including exudated and/or infected wounds.
Patent CA-2415703-A1 (CA)
Title: Method and equipment in connection with a paper machine or a paper web finishing apparatus
Inventor: ALMI JARI
IPC: B65H23/188
Filed: 2003-01-07
Abstract: A variable representing runnability of a paper web to be manufactured with a paper machine or processed with a finishing apparatus is measured and the speed difference between operational groups of the paper machine and/or the finishing apparatus is adjusted on the basis of the measurement of said variable such that the moisture profile of the paper web is measured substantially along the entire width of the paper web, the minimum and maximum values for moisture are defined on the basis of the moisture profile, a drawing window describing the allowable tension to be directed to the paper web is defined, the lower and upper limits of the drawing window being defined on the basis of the minimum and maximum values for moisture, and the speed difference between the operational groups is adjusted so that the paper web tension is within the range defined by the drawing window.
Patent CA-2417148-A1 (CA)
Title: Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
Inventor: BREAULT GLORIA ANNE
IPC: A61P35/02
Filed: 2001-08-30
Abstract: Compounds of the formula (I): wherein R1, R2, R3, R4, R5, R6, p, q, and n ar e as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm - blooded animal, such as man.
Patent CA-2417796-A1 (CA)
Title: Method and apparatus for patch-clamp measurements on cells
Inventor: LEPPLE-WIEN-HUES ALBRECHT
IPC: C12Q1/02
Filed: 2001-07-31
Abstract: The invention shows a method for patch-clamp experiments on cells or similar  structures, where at least one cell is inserted into the lumen of a capillar y and is positioned inside the capillary so, that a sufficiently tight seal wi th a resistance exceeding 1, preferably 10 GigaOhm develops between cell membra ne and inner surface of the capillary. Along its length said capillary has at least at one position a smaller inner diameter than the outer diameter of sa id cell. Preferably the cell is inserted and positioned in the capillary by pressure, suction, sedimentation or centrifugation of a suspension or soluti on containing said cell. An apparatus for performing experiments using this method is described.
Patent CA-2420721-A1 (CA)
Inventor: BLESA STEPHANE
IPC: C12N15/10
Filed: 2001-08-24
Abstract: The invention concerns the field of molecular biology and more particularly that of mutagenesis. It concerns a method of high-rate directed mutagenesis, that is the formation of numerous directed mutants in reduced time and with reduced number of steps. Said method is therefore referred to as massive directed mutagenesis.
Patent CA-2422250-A1 (CA)
Inventor: ROTH HERRMANN
IPC: A23K20/116
Filed: 2001-09-14
Abstract: The invention relates to an animal feed, containing conventional feed materials such as cereal or cereal products, maize, proteins and aromatic amino acids, vitamins, mineral aggregates such as salts, phosphates, lime, enzymes and similar and an effective amount of one or several benzophenanthridine alkaloids, or derivatives or synthetic analogues thereof  to reduce the enzymatic degradation of the essential aromatic amino acids. T he invention further relates to the use of benzophenanthridine alkaloids, derivatives or synthetic analogues thereof and a medicament.
Patent CA-2422859-A1 (CA)
Inventor: THEEUWES FELIX
IPC: A61K9/00
Filed: 2001-09-19
Abstract: The present invention features devices and methods for delivery of drug to an internal organ surface by delivery of drug directly to the surface of the organ such that the drug traverses the organ surface and enters the organ tissue. The device is in the form of an implantable drug delivery patch comprising a first layer, which is generally substantially drug-impermeable.  When the first layer is placed on an outer surface of an organ, a drug reservoir is defined by the first layer and the organ surface.
Patent CA-2428074-A1 (CA)
Inventor: SHAW ERICH
IPC: C12M1/34
Filed: 2001-11-08
Abstract: Procédé de détection et de dénombrement de micro-organismes viables. Le procédé comporte les étapes consistant à prévoir une composition liquide contenant un ou plusieurs marqueurs incorporés dans un précurseur liquide sol-gel ; à enduire une lame transparente d'une fine couche uniforme de la composition de précurseur liquide sol-gel ; à séparer les micro-organismes d'un échantillon liquide à analyser en faisant passer l'échantillon à travers un filtre ; et à mettre ensuite le filtre en contact étroit avec la lame enduite par voie sol-gel ; à incuber le filtre conjointement avec la lame enduite par voie sol-gel pendant une durée et à une température appropriées en vue d'activer la fixation des marqueurs par les micro-organismes ; à irradier la lame enduite par voie sol-gel à l'aide d'une source d'énergie externe, de manière à produire des signaux détectables émis par les marqueurs fixés par les micro-organismes ; à saisir des images des signaux détectables émis par les micro-organismes, et à analyser ces images au moyen d'un système informatique en vue d'identifier et de dénombrer les micro-organismes.
Patent CA-2428190-A1 (CA)
Title: Combination window covering
Inventor: NIEN MING
IPC: E06B9/264
Filed: 2003-05-08
Abstract: A combination window covering is constructed to include an elongated barrel fastened rotatably with a top side of a window, a bottom rail below the barrel, slats arranged in parallel between the barrel and the bottom rail, front and back ladder tapes connected in parallel between the barrel and the bottom rail at front and back sides of the slats and joining the slats, and a light-admitting flexible sheet. The flexible sheet has first and second ends respectively fixedly fastened to the barrel at two sides, a front half extended from the first end and suspended at the front side of the slats, a back half extended from the second end and suspended at the back side of the slats, and a middle part connected between the front half and the back half and moveably passing over the bottom rail.
Patent CA-2428819-A1 (CA)
Inventor: FILIPPOV ANDREI GREGORY
IPC: E21B43/10
Filed: 2002-01-02
Abstract: Plastically deforming and radially expanding a first tubular member (155) within a wellbore (10) form a mono-diameter wellbore casing. A second tubular member (200) is then plastically deformed and radially expanded, overlapping the first tubular member (155). Then the second tubular (200) and the overlapped portion of the first tubular (155) are expanded.
Patent CA-2432481-A1 (CA)
Title: Molding composite objects
Inventor: SAWYER MICHAEL
IPC: B29C71/02
Filed: 2003-06-17
Abstract: Methods for molding a surround over a liner to form a composite shell are provided. The liner is placed in a mold and molten surround material is injected into the mold so as to surround the liner. A surface of a protrusion of the liner abuts the mold so that the surface is exposed and is substantially flush with an exterior surface of the surround after the composite shell is removed from the mold. Molten surround material flows into a slot in a perimeter of the protrusion so that when the surround material solidifies, a rib of surround material extends into the slot to form a pressure seal between the liner and the surround. An adhesive is applied to the liner before placing the liner in the mold for reducing relative movement between the liner and surround as the surround material solidifies and the liner and surround cool.
Patent CA-2434837-A1 (CA)
Inventor: DREIER ROMEO
IPC: C08L101/00
Filed: 2002-02-28
Abstract: The present invention relates to pyrifone azo dyes of formula (1), wherein A  is the radical of a diazo component of the benzene, naphthalene, diphenyl, azobenzene, thiophene, benzothiazole, benzoisothiazole, thiadiazole, indazol e, benzotriazole, pyrazole, anthraquinone, naphttholic acid imide, chromone, phthalimide or diphenylene oxide series, R1 is hydrogen, unsubstituted or hydroxyl- or phenyl- substituted C1-C6alkyl, it being possible for the alkyl  chain to be interrupted from C3 upwards by one or more oxygen atoms, or has the meanings of R2, R2 is a radical of formulae (2), (3), (4), (5), (6), or (7), wherein B is a bridging member, R4 is alkyl or aryl, R5 and R6 are each  independently of the other alkyl, aryl or heteroaryl and A is as defined for  formula (1), or R1 and R2 toghether with the nitrogen atom in NR1R2 form a heterocyclic ring, Y is cyano, -CONH2 or CH2SO3H, and n is an integer from 2  to 6, to a process for their preparation and to their use in the production coloured plastics or polymeric colour particles.
Patent CA-2435314-A1 (CA)
Inventor: GILMORE CARL D
IPC: E02F3/48
Filed: 2003-07-17
Abstract: A dragline excavating machine includes a gearless direct drive AC drive motor for driving each of the hoist and the drag drums in the system. The gearless AC motor is driven using a digital system which receives AC power from the utility system rectifies the power using active front end circuits, and converts the resultant DC to a frequency controlled AC using an inverter circuit. The resultant AC signal is employed to drive the gearless AC motor, resulting in reduced harmonic distortion unity or leading power factor, and increased efficiency, reduced operating costs, and reduced mean time between failure.
Patent CA-2436129-A1 (CA)
Title: Appareil utilise pour l'analyse chromatographique en phase liquide a haute temperature
Inventor: GERNER YURI
IPC: G01N30/54
Filed: 2002-09-20
Abstract: La présente invention concerne un système (Fig. 8) utilisé pour l'analyse chromatographique en phase liquide à haute température. Il comporte un tube de transport de phase mobile (202) chargé de transporter, de par sa configuration, la phase mobile depuis une source jusqu'aux différents instruments de chromatographie (206) du système. Le système comporte également un réchauffeur (212) qui de par son couplage au tube de transport de phase mobile, servant à amener à la phase mobile la température voulue. La colonne de chromatographie (206), qui est fonctionnellement couplée au réchauffeur, est équipée d'un dispositif thermostatique (204) assurant le maintien de la colonne à une température définie. En outre, un échangeur thermique monté à contre-courant (212) est chargé de l'échange de chaleur de la phase mobile sortante vers la phase mobile entrante via des structures de transfert thermoconductrices. Selon un mode de réalisation particulier, la phase mobile transitant par la colonne de chromatographie est maintenue sensiblement en adiabatisme.
Patent CA-2437820-A1 (CA)
Title: Endomural therapy
Inventor: SLEPIAN MARVIN J
IPC: A61K38/17
Filed: 2002-02-08
Abstract: Methods, devices and materials for the treatment or repair, replacement, transplantation or augmentation of tissues in endomural zones specifically by open surgical, minimally invasive or percutaneous transmural or trans parenchymal application of polymeric material alone or in combination with bioactive agents or cells, have been developed. These methods and systems are useful to repair, after function, replace function or augment function of the central or endomural aspects of solid organs or tubular body structures.
Patent CA-2439584-A1 (CA)
Title: Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
Inventor: KOREN BELLY
IPC: A61F2/958
Filed: 2002-02-28
Abstract: A method of inducing liver regeneration in a damaged liver tissue region of an individual is provided. The method including the step of providing at least two distinct growth factors to the damaged liver tissue region of the individual, at least one of the at least two distinct growth factors being an angiogenic factor.
Patent CA-2439690-A1 (CA)
Title: Modified interferon alpha with reduced immunogenicity
Inventor: BAKER MATTHEW
IPC: C12N15/09
Filed: 2002-03-01
Abstract: The present invention relates to polypeptides to be administered especially to humans and in particular for therapeutic use. The polypeptides are modified polypeptides whereby the modification results in a reduced propensity for the polypeptide to elicit an immune response upon administration to the human subject. The invention in particular to the modification of human interferon alpha and specifically interferon alpha 2(INF.alpha.2) to result in proteins that are substantially non-immunogenic or less immunogenic than any non-modified counterpart when use in vivo.
Patent CA-2440419-A1 (CA)
Title: Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
Inventor: SKILES JERRY W
IPC: C07D211/32
Filed: 2002-03-13
Abstract: Compounds of the formula (I) wherein R represents OH or NHOH; R1 represents hydrogen, optionally substituted lower alkyl, aryl-lower alkyl, cycloalkyl- lower alkyl, or acyl derived from a carboxylic acid, from a carbonic acid, from a carbamic acid of from a sulfonic acid; R2 represents biarylsulfonyl o r aryloxyarylsufonyl; R3 represents hydrogen, optionally substituted lower alkyl, aryl-lower alkyl, cycloalkyl-lower alkyl or acyl derived from a carboxylic acid, from a carbonic acid or form a carbamic acid; R4 and R5 represent independently hydrogen, lower alkyl, lower alkoxycarbonyl, aryl- lower alkyl or cycloalkyl-lower alkyl; m is zero, 1, 2 or 3; pharmaceuticall y acceptable prodrug derivatives thereof; pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising said compounds; and their us e for inhibiting matrix degrading metalloproteinases and preventing or treatin g matrix metalloproteinase dependent conditions in mammals.
Patent CA-2441161-A1 (CA)
Inventor: KRIVAN HOWARD C
IPC: A61K9/00
Filed: 2000-06-12
Abstract: In order to prevent conception and/or infection by sexually transmitted diseases (STDs) one or more lectins capable of binding sperm or agglutinable components of male ejaculate and/or the pathogenic microorganisms responsibl e for STDs or the carbohydrate moieties expressed on cell surfaces by which th e microorganisms bind to the cells, are administered to the vagina prior to sexual intercourse. The lectins prevent conception by binding to the sperm o r agglutinable components of male ejaculate to render the sperm incapable of fertilization. They also bind to the pathogenic microorganisms to render the m non-pathogenic or to carbohydrates expressed on cell surfaces to prevent infection by the microorganisms or treat such infections. Lectins can also b e administered to treat sexually transmitted vaginal infections. The lectins c an also be applied to or contained within a condom. The condom may carry the lectins either within the hollow interior or the condom or impregnated into, linked to, or coated upon its membrane body. Lectins may also be incorporate d in the same way into a surgical glove for protection against infection by pathogenic microorganisms.
Patent CA-2442938-A1 (CA)
Inventor: KUMAR SURINDER
IPC: H04L27/36
Filed: 2003-09-26
Abstract: The present inventions provide methods and systems for optimizing the power consumption of a power amplifier used to amplify a QAM modulated signal by dynamically adjusting its compression point. The compression point is adjusted based upon the instantaneous peak value of the base band QAM signal.
Patent CA-2443426-A1 (CA)
Inventor: WIEBE JACOB R
IPC: B60S3/04
Filed: 2003-09-30
Abstract: A double boom arrangement for use in a car wash includes a first and a second boom assembly mounted side by side on a respective rotatable coupling so that a horizontal portion of the hose of each boom can rotate about a vertical axis in a generally horizontal plane with the remainder of the hose extending downwardly from the horizontal plane at an outer end of the boom. Each boom has a parking arrangement for moving the boom and the hose to a parked location extending 180 degree away from the other boom. The boom includes a first inner and a second outer boom portion with the inner and outer portions connected by a second swivel coupling parallel to the first and spaced outwardly therefrom, The inner boom portion is mounted on a bracket for pivotal movement about a horizontal axis and constrained by two horizontal springs above the pivot axis. The springs are mounted at opposite ends of a rod bent around the pivot axis where each is compressed as the first boom portion pivots downwardly. The second boom portion uses a spring wire support to provide a second pivot action.
Patent CA-2446311-A1 (CA)
Title: 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
Inventor: WALPOLE CHRISTOPHER
IPC: A61P25/00
Filed: 2002-05-16
Abstract: Compounds of general formula I[Chemical formula should be inserted here.  Please see paper copy] R1 is selected from any one of phenyl, pyridinyl, pyrrolyl, thienyl, furanyl, imidazolyl, triazolyl, and pyridine N-oxide; where each R1 phenyl ring and R1 heteroaromatic ring may optionally and independently be further substituted by 1,2 or 3 substituents selected from straight and branched C1-C6alkyl, NO2, CF3, C1-C6alkoxy, chloro, fluoro, bromo, and iodo. The substitutions on the phenyl ring and on the heteroaromatic ring may take place in any position on said ring systems; are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts and pharmaceutical compositions comprising the novel compounds and their use in therapy, in particular in the management of pain, anxiety and functional gastrointestinal disorders.
Patent CA-2446333-A1 (CA)
Inventor: WOODS RICHARD R
IPC: C01B3/38
Filed: 2002-05-02
Abstract: Un appareil de production d'hydrogène utile pour produire de l'hydrogène comprend une première entrée (85) prévue pour mélanger un écoulement d'eau sous forme liquide (17) avec un écoulement de gaz d'alimentation (21) pour produire un écoulement mixte (19) formé de gaz d'alimentation et d'eau et un mécanisme de chauffage (66) prévu pour chauffer l'écoulement mixte (19) formé du gaz d'alimentation et de l'eau à une température suffisante pour évaporer l'eau présente dans l'écoulement mixte (19) gaz d'alimentation/eau afin de produire un écoulement de gaz d'alimentation humidifié (84). Une deuxième entrée (68) est prévue pour mélanger l'écoulement de gaz d'alimentation humidifié (84) avec un combustible hydrocarboné (11) afin de produire un mélange réactif reformeur formé de combustible, d'oxydant et de vapeur (69). Un constituant (70) reformeur à base de vapeur et de méthane fait réagir le combustible hydrocarboné et la vapeur du mélange réactif reformeur (69), ceci produisant un gaz (72) issu de reformeur enrichi en hydrogène.